TVWM
KOSP

Tower View Wealth Management’s K O S PHARMACEUTICALS INC KOSP Stock Holding History

Tower View Wealth Management’s Portfolio KOSP Stock Details KOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,602
Closed -$175K – 195
2023
Q2 		$175K Buy
+1,602
New +$175K 0.12% 58

Tower View Wealth Management's KOSP Position: Q3 2023 in Review

Tower View Wealth Management sold out of K O S PHARMACEUTICALS INC (KOSP) in Q3 2023, closing a stake of 1,602 shares — an estimated $175K sold.

Tower View Wealth Management first reported a position in KOSP in Q2 2023 and held it in 1 quarter. The position peaked at $175K in Q2 2023. 0 funds tracked by Wall St. Rank hold KOSP as of Q3 2023.

  • Tower View Wealth Management reported no remaining K O S PHARMACEUTICALS INC position as of Q3 2023 after selling out during the quarter.
  • Tower View Wealth Management sold 1,602 K O S PHARMACEUTICALS INC shares in Q3 2023, an estimated $175K.
  • Tower View Wealth Management first reported a position in K O S PHARMACEUTICALS INC in Q2 2023 and held it in 1 quarter.
  • Tower View Wealth Management's K O S PHARMACEUTICALS INC position peaked at $175K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held K O S PHARMACEUTICALS INC as of Q3 2023.

Based on Tower View Wealth Management's 13F filing for Q3 2023, filed 31 Oct 2023.